This is the authors' abstract. We don't add key points for this paper.
Clinicians avoid biopsy in Chronic Kidney Disease (CKD) as there is high risk of bleed. However there are conditions where benefits outweigh risks like ascertaining cause of CKD in patients going for transplant and in those where reversibility is expected after some therapeutic intervention.There is paucity of data on the outcomes of renal biopsy in CKD patients. This study aims to study the clinical profile, diagnosis, therapeutic intervention and complications in biopsied CKD patients.
No takes yet. Share an insight, caveat, or question.
Mohakuda et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: